{
  "id": 2882807,
  "title": "Danaher vs. Medtronic: Which Healthcare Recovery Story Has More Upside?",
  "url": "https://urgent.news/2026/08/23/danaher-vs-medtronic-which-healthcare-recovery-story-has-more-upside",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-23T22:10:12.000Z",
  "source": {
    "name": "Yahoo Finance",
    "slug": "yahoo-finance",
    "url": "https://finance.yahoo.com/healthcare/articles/danaher-vs-medtronic-healthcare-recovery-221012046.html"
  },
  "original_language": "en",
  "account": "Healthcare investors are observing signs of recovery across several segments of the industry. Danaher (NYSE:DHR) is experiencing growth due to increased demand in life sciences, while Medtronic (NYSE:MDT) is showing progress from years of investment in new products and operational execution. The investors are trying to determine which recovery story presents greater long-term upside potential. Medtronic's turnaround is being driven by its growth platforms, which are now contributing significantly to revenue. Its latest fiscal quarter results indicate a 9.9% revenue growth, with organic growth at 6.6%. Danaher's recovery hinges on improving spending across its life sciences business, which has shown the strongest performance in years. However, Medtronic's recovery has largely come from a few fast-growing platforms, and investors will need to see broader growth across the company before considering its turnaround complete.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}